Cannell & Co. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$462,954
+1.4%
4,545
+0.5%
0.02%
+6.7%
Q2 2023$456,517
+5.9%
4,524
-3.5%
0.02%0.0%
Q1 2023$431,112
-0.8%
4,686
-2.2%
0.02%
-6.2%
Q4 2022$434,640
+21.4%
4,791
+1.8%
0.02%
+14.3%
Q3 2022$358,000
-16.9%
4,706
-7.7%
0.01%
-6.7%
Q2 2022$431,000
-10.6%
5,096
-7.3%
0.02%
+7.1%
Q1 2022$482,000
+0.2%
5,4960.0%0.01%0.0%
Q4 2021$481,000
-9.4%
5,496
-15.4%
0.01%
-12.5%
Q3 2021$531,000
-32.5%
6,496
-24.7%
0.02%
-33.3%
Q2 2021$787,000
-6.3%
8,627
-12.2%
0.02%
-7.7%
Q1 2021$840,000
-19.0%
9,827
-10.5%
0.03%
-23.5%
Q4 2020$1,037,000
+8.6%
10,9770.0%0.03%
-2.9%
Q3 2020$955,000
-10.2%
10,977
-9.9%
0.04%
-16.7%
Q2 2020$1,064,000
+6.0%
12,1770.0%0.04%
-12.5%
Q1 2020$1,004,000
-51.9%
12,177
-44.8%
0.05%
-35.1%
Q4 2019$2,088,000
+14.3%
22,052
+4.9%
0.07%
+7.2%
Q3 2019$1,827,000
-0.4%
21,027
+4.7%
0.07%0.0%
Q2 2019$1,835,000
-6.2%
20,092
-1.3%
0.07%
-9.2%
Q1 2019$1,957,000
+13.1%
20,352
+1.0%
0.08%0.0%
Q4 2018$1,730,000
-0.4%
20,1560.0%0.08%
+24.6%
Q3 2018$1,737,000
+10.4%
20,156
-3.2%
0.06%
+3.4%
Q2 2018$1,574,000
-6.1%
20,831
+0.5%
0.06%
-6.3%
Q1 2018$1,676,000
-9.6%
20,731
-6.2%
0.06%
-1.6%
Q4 2017$1,855,000
-2.2%
22,0970.0%0.06%
-3.0%
Q3 2017$1,897,000
+2.9%
22,0970.0%0.07%
+3.1%
Q2 2017$1,844,000
+15.5%
22,097
+2.8%
0.06%
+14.3%
Q1 2017$1,597,000
-3.9%
21,497
-5.7%
0.06%
-6.7%
Q4 2016$1,661,000
-9.5%
22,797
-1.9%
0.06%
-10.4%
Q3 2016$1,836,000
-9.5%
23,247
-5.5%
0.07%
-9.5%
Q2 2016$2,029,000
+13.9%
24,5970.0%0.07%
+15.6%
Q1 2016$1,782,000
-17.8%
24,597
-2.4%
0.06%
-8.6%
Q4 2015$2,168,000
-6.4%
25,1970.0%0.07%
-6.7%
Q3 2015$2,316,000
+29.7%
25,197
+38.8%
0.08%
+47.1%
Q2 2015$1,785,000
-2.7%
18,147
-2.4%
0.05%
-3.8%
Q1 2015$1,834,000
+1.3%
18,597
-4.9%
0.05%
-1.9%
Q4 2014$1,811,000
-6.6%
19,547
-1.8%
0.05%
-11.5%
Q3 2014$1,939,000
+3.3%
19,897
-4.1%
0.06%
+5.2%
Q2 2014$1,877,000
-37.9%
20,737
-41.7%
0.06%
-41.4%
Q1 2014$3,023,00035,5580.10%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders